Ischemia modified albumin changes - review and clinical implications.
about
Biomonitoring Human Albumin Adducts: The Past, the Present, and the FutureMeasurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans.Oxidatively modified forms of albumin in patients with risk factors of metabolic syndromeEffect of curcumin against oxidation of biomolecules by hydroxyl radicalsClinical significance of ischemia-modified albumin in the diagnosis of doxorubicin-induced myocardial injury in breast cancer patients.The elevated copper binding strength of amyloid-β aggregates allows the sequestration of copper from albumin: a pathway to accumulation of copper in senile plaquesParaoxonase 1 in chronic kidney failurePotential blood biomarkers for stroke.Evaluation of serum ischemia modified albumin levels in acute rheumatic fever before and after therapy.Ischemia-modified albumin levels in children with chronic liver disease.Correlation of ischemia-modified albumin levels and histopathologic findings in experimental ovarian torsion.Role of ethyl pyruvate in systemic inflammatory response and lung injury in an experimental model of ruptured abdominal aortic aneurysm.The effects of spinal, inhalation, and total intravenous anesthetic techniques on ischemia-reperfusion injury in arthroscopic knee surgery.Ischemia modified albumin can predict necrosis at incarcerated hernias.The role of ischemia modified albumin in acute pulmonary embolism.Role of ischemia-modified albumin in patients with acute decompensated heart failure.Ischemia modified albumin in early neonatal sepsis.Synergistic Cardioprotective Effects of Combined Chromium Picolinate and Atorvastatin Treatment in Triton X-100-Induced Hyperlipidemia in Rats: Impact on Some Biochemical Markers.Ischemia-modified albumin as a marker of vascular dysfunction and subclinical atherosclerosis in β-thalassemia major.Evaluation of maternal serum ischemia modified albumin and total antioxidant status in ectopic pregnancy.Association of Endocan, Ischemia-Modified Albumin, and hsCRP Levels With Endothelial Dysfunction in Type 2 Diabetes Mellitus.Changes in ischemia-modified albumin in myocardial toxicity induced by anthracycline and docetaxel chemotherapy.The value of serum ischemia-modified albumin for assessing liver function in patients with chronic liver disease.Haemostatic risk factors in dyslipidemic rabbits: role of 10-dehydrogingerdione as a new hypolipemic agent.An Overview of Celiac Disease in Childhood Type 1 DiabetesIschemia-modified albumin: Crosstalk between fatty acid and cobalt binding
P2860
Q28468289-1843B662-D514-40EF-BBCE-17A4E7B02FB9Q33862472-E416041D-E0F4-428B-9488-198A765B66CDQ34157415-86F56C3F-906B-4540-B677-C6322FD7D626Q34617929-174AA7E8-971C-437A-B7F3-271B26632D55Q35041318-7CCDF4E3-EF38-49A7-9ADB-4942DFA1CA4EQ36553193-190CDEDF-9DB6-44A6-BA63-114F74B74DC7Q38004498-6F669EB1-7402-44A9-B753-BA37DE6AB089Q38042459-BD0696F2-2830-4E68-AB2B-1C9DCB2B5B81Q40242748-8BF34872-A2CB-4167-B527-D5B3BD17C638Q41552571-F2D96C5D-058B-4B50-837A-95FA4F987568Q41838001-96E3B2AD-6615-4B53-8E24-27C0A5FE69A3Q41921117-6417FB29-34B8-4023-88E8-001E544C28B6Q41962124-F619F57D-144C-43FF-A372-726E873F9066Q41988208-5B55FC04-9AF9-47AC-AEF3-8C77A84784E7Q42231055-C623BCA4-1EB5-40E1-9A90-615329B465A4Q42318485-44654934-D47C-423F-9B09-2E96456F6913Q44789621-3F8BF231-EFDB-45A2-B973-3B3808424E00Q46414850-AF69D33E-FF23-4D57-9F54-AFB841AB8E8BQ46460675-CD386A9B-979B-4D71-BE04-84BFF056CDD1Q47238481-4B9ABF72-5324-4EFE-8399-1978DE4C0421Q47367683-9E498CC0-D4AA-4542-BBE1-1EFA74B92F52Q47969502-2A4CA228-76EC-4801-9200-C44CEE194A21Q50514189-06442936-3050-4FEB-BC65-B08E3825FC59Q53819348-F4F0A271-0944-4BFE-947B-D4968120D13EQ56891624-5698FF97-A82E-4B21-88EB-46E32CB39C2DQ58805331-BC18F0F5-6105-40FF-9D42-0CA15ADBE9F8
P2860
Ischemia modified albumin changes - review and clinical implications.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Ischemia modified albumin changes - review and clinical implications.
@en
Ischemia modified albumin changes - review and clinical implications.
@nl
type
label
Ischemia modified albumin changes - review and clinical implications.
@en
Ischemia modified albumin changes - review and clinical implications.
@nl
prefLabel
Ischemia modified albumin changes - review and clinical implications.
@en
Ischemia modified albumin changes - review and clinical implications.
@nl
P2093
P2860
P356
P1476
Ischemia modified albumin changes - review and clinical implications.
@en
P2093
Eftihia Sbarouni
Panagiota Georgiadou
Vassilis Voudris
P2860
P304
P356
10.1515/CCLM.2011.037
P577
2010-11-18T00:00:00Z